SFM
PBYI icon

Systematic Financial Management’s Puma Biotechnology PBYI Stock Holding History

Systematic Financial Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-27,150
Closed -$283K – 391
2020
Q2 		$283K Buy
+27,150
New +$281K 0.01% 404

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Systematic Financial Management's PBYI Position: Q3 2020 in Review

Systematic Financial Management sold out of Puma Biotechnology (PBYI) in Q3 2020, closing a stake of 27,150 shares — an estimated $283K sold.

Systematic Financial Management first reported a position in PBYI in Q2 2020 and held it in 1 quarter. The position peaked at $283K in Q2 2020. 128 funds tracked by Wall St. Rank hold PBYI as of Q3 2020.

  • Systematic Financial Management reported no remaining Puma Biotechnology position as of Q3 2020 after selling out during the quarter.
  • Systematic Financial Management sold 27,150 Puma Biotechnology shares in Q3 2020, an estimated $283K.
  • Systematic Financial Management first reported a position in Puma Biotechnology in Q2 2020 and held it in 1 quarter.
  • Systematic Financial Management's Puma Biotechnology position peaked at $283K in Q2 2020.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2020.

Based on Systematic Financial Management's 13F filing for Q3 2020, filed 12 Nov 2020.